DeepMed Research

NATIONAL INSTITUTE ON DRUG ABUSE AND ADDICTION

🇵🇰Pakistan

Country: 🇵🇰Pakistan

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood Swings

Phase 2

Completed

Conditions: Mood Disorders

First Posted Date: 2005-09-22

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 15

Registration Number: NCT00217932

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users

Phase 4

Completed

Conditions: Substance-Related Disorders
Hepatitis

Interventions: Drug: Pegylated Interferon

First Posted Date: 2005-09-19

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 21

Registration Number: NCT00194480

Locations: 🇺🇸
Harborview Medical Center, 325 Ninth Ave 1EC32, Seattle, Washington, United States

A Transtheoretical Model Group Therapy for Cocaine

Phase 1

Completed

Conditions: Cocaine Use Disorders

Interventions: Behavioral: Education & Advice
Behavioral: Transtheoretical Model Group Therapy

First Posted Date: 2005-09-15

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 138

Registration Number: NCT00178776

Locations: 🇺🇸
University of Texas Houston Mental Sciences Institute, Houston, Texas, United States

Atomoxetine for the Treatment of Cannabis Dependence

Phase 2

Completed

Conditions: Cannabis Dependence

Interventions: Drug: Atomoxetine

First Posted Date: 2005-09-14

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 16

Registration Number: NCT00167297

Locations: 🇺🇸
University of Pennsylvania Treatment Rersearch Center, Philadelphia, Pennsylvania, United States

Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users

Not Applicable

Completed

Conditions: Opioid-Related Disorders

First Posted Date: 2005-09-12

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 7

Registration Number: NCT00158236

Locations: 🇺🇸
Johns Hopkins University (BPRU) Bayview Campus, Baltimore, Maryland, United States

Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2

Phase 2

Completed

Conditions: Tobacco Use Disorder
Smoking Cessation

Interventions: Drug: Usual Care
Other: Smoking Reduction

First Posted Date: 2005-09-12

Last Posted Date: 2017-01-10

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 200

Registration Number: NCT00158158

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1

Phase 2

Completed

Conditions: Smoking Cessation
Tobacco Use Disorder

Interventions: Drug: Nicotine patch
Dietary Supplement: Folic Acid
Drug: Nicotine Replacement Therapies

First Posted Date: 2005-09-12

Last Posted Date: 2017-01-10

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 128

Registration Number: NCT00158171

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2

Completed

Conditions: Tobacco Use Disorder

First Posted Date: 2005-09-12

Last Posted Date: 2017-01-10

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 72

Registration Number: NCT00158145

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Rivastigmine For Methamphetamine Dependent Individuals

Phase 1

Completed

Conditions: Substance-Related Disorders

First Posted Date: 2005-09-12

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 18

Registration Number: NCT00158210

Locations: 🇺🇸
University of California - Los Angeles, Los Angeles, California, United States

The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1

Phase 2

Completed

Conditions: Cocaine
Behavior Therapy
Contingency Management
Opioid Dependence
Heroin Dependence
LAAM
Alcohol & Drug Use
Substance-Related Disorders

First Posted Date: 2005-09-12

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 140

Registration Number: NCT00158288

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy